spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Baraya Extended Care secures $124m for Saudi Arabia expansion

Long-term care and rehabilitation services provider Baraya Extended Care has closed a Series B fundraising round, securing $124m to expand its network of inpatient facilities and outpatient clinics across Saudi Arabia.
Led by TVM Capital Healthcare through its TVM Healthcare Afiyah Fund, the funding also includes contributions from co-investors and exceeded its initial target.

Baraya Extended Care CEO Jad Halaby said: “With TVM Capital Healthcare’s support and expertise in this healthcare vertical, we are uniquely positioned to combine international standards with local expertise, improving outcomes and quality of life for patients and families across Saudi Arabia.”

This financial milestone arrives at a time when the nation is grappling with an aging population, a rise in chronic conditions, and a growing demand for specialised post-acute care.

These challenges are part of the broader context of Saudi Arabia’s Vision 2030 and Health Sector Transformation Program.
Baraya Extended Care, established in 2023, has already inaugurated two outpatient rehabilitation clinics in Jeddah and Riyadh, delivering over 9,000 sessions monthly.

Hot this week

Novo Nordisk Lowers Full-Year Profit Guidance in New CEO’s Maiden Quarter

Wegovy-maker Novo Nordisk lowered its full-year profit forecast on...

Compass Pathways to expedite launch timing of its experimental depression therapy

Drug developer Compass Pathways said on Tuesday it is...

Pharma Investment to establish manufacturing facility at SOHAR Freezone

SOHAR Port and Freezone has signed a land lease...

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up

Novo Nordisk and Pfizer have revised their bids for...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img